Antiviral Medicines Assessment- What Is Driving High Clinical Added Value In France?

Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.3062
https://www.valueinhealthjournal.com/article/S1098-3015(17)33397-1/fulltext
Title : Antiviral Medicines Assessment- What Is Driving High Clinical Added Value In France?
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)33397-1&doi=10.1016/j.jval.2017.08.3062
First page : A791
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 2145
Categories :
Tags :
Regions :
ViH Article Tags :